- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05451628
Anatomy-Based Fitting in Unexperienced Cochlear Implant Users (ABFmulti)
December 11, 2023 updated by: Universitair Ziekenhuis Brussel
Severe to profound hearing loss affects 0,8% of the global population.
For these people, a conventional hearing aid often does not provide sufficient benefit.
However, these people can benefit from a cochlear implant (CI).
A CI needs to be individually programmed (fitted) for each recipient.
A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception.
At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account.
In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emilie Heuninck
- Phone Number: +3224749772
- Email: emilie.heuninck@uzbrussel.be
Study Locations
-
-
-
Brussel, Belgium, 1090
- Recruiting
- UZ Brussel
-
Contact:
- Vedat Topsakal, Prof
-
Contact:
- Emilie Heuninck
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18 years
- Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s)
- Post-operative Computed Tomography (CT) scan of the CI electrode available
- Pre-operative result of pure-tone audiometry, speech test in quiet and in noise available
- Subject implanted with MED-EL cochlear implant(s)
- Subjects received a Flex28, FlexSoft or Standard electrode
- Subject planned to receive a SONNET 2 or RONDO 3 audio processor on the newly implanted side
- Audio processor not yet activated on the newly implanted side
- The most apical active electrode contact has to be inserted at least 450°
- Minimum of 10 active channels can be activated
- Fluent in the language of the test centre
- Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure
Exclusion Criteria:
- Lack of compliance with any inclusion criteria
- Electric Acoustic Stimulation (EAS) user (user of an EAS audio processor)
- Implanted with C40+, C40X and C40C
- Implanted with an Auditory Brainstem Implant (ABI) or Split electrode array
- Anything that, in the opinion of the Investigator, would place the subject at increased risk or pre-clude the subject's full compliance with or completion of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Default CI fitting
Programming of cochlear implant speech processor according to standard clinical care
|
Programming of cochlear implant speech processor according to standard clinical care
|
|
Active Comparator: Anatomy-based CI fitting
Programming of cochlear implant speech processor with anatomy-based fitting
|
Programming of cochlear implant speech processor with anatomy-based fitting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Speech recognition test in quiet (S0): percentage correctly identified phonemes
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
Speech recognition test in quiet (S0): percentage correctly identified phonemes
Time Frame: 6 months post-activation
|
6 months post-activation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
|
Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR
Time Frame: 6 months post-activation
|
6 months post-activation
|
|
|
Result of the pitch matching test: frequency difference in semitones
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
|
Result of the pitch matching test: frequency differences in semitones
Time Frame: 6 months post-activation
|
6 months post-activation
|
|
|
Result of the perception of timbre test: Score on Visual Analog Scale (VAS)
Time Frame: 3 months post-activation
|
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
|
3 months post-activation
|
|
Result of the perception of timbre test: Score on Visual Analog Scale (VAS)
Time Frame: 6 months post-activation
|
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
|
6 months post-activation
|
|
Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
|
Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure
Time Frame: 6 months post-activation
|
6 months post-activation
|
|
|
Result of the speech contrast discrimination test: Psychometric function of phoneme categorization
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
|
Result of the speech contrast discrimination test: Psychometric function of phoneme categorization
Time Frame: 6 months post-activation
|
6 months post-activation
|
|
|
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit
Time Frame: 1 day visit (At the activation of the sound processor)
|
1 day visit (At the activation of the sound processor)
|
|
|
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
|
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit
Time Frame: 6 months post-activation
|
6 months post-activation
|
|
|
Datalogging data: Average numbers of hours per day
Time Frame: 2 weeks post-activation
|
2 weeks post-activation
|
|
|
Datalogging data: Average numbers of hours per day
Time Frame: 1 months post-activation
|
1 months post-activation
|
|
|
Datalogging data: Average numbers of hours per day
Time Frame: 3 months post-activation
|
3 months post-activation
|
|
|
Datalogging data: Average numbers of hours per day
Time Frame: 6 months post-activation
|
6 months post-activation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Vedat Topsakal, Prof., UZB-VUB
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2022
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
January 1, 2025
Study Registration Dates
First Submitted
June 2, 2022
First Submitted That Met QC Criteria
July 8, 2022
First Posted (Actual)
July 11, 2022
Study Record Updates
Last Update Posted (Actual)
December 12, 2023
Last Update Submitted That Met QC Criteria
December 11, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC-2021-437
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensorineural Hearing Loss
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
University College, LondonUnknownSensorineural Hearing Loss | Sensory Hearing Loss | Sensorineural Hearing Loss in Left Ear | Sensorineural Hearing Loss in Right Ear | Sensorineural HearingUnited Kingdom
-
Fundación Pública Andaluza para la gestión de la...RecruitingBilateral Sensorineural Hearing Loss | Unilateral Sensorineural Hearing LossSpain
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
-
Far East Bio-Tec Co., LtdNot yet recruitingTinnitus | Sudden Sensorineural Hearing Loss (SSNHL)Taiwan
-
Assiut UniversityNot yet recruitingSudden Sensorineural Hearing Loss (SSNHL)Egypt
-
Auris Medical, Inc.TerminatedHearing Loss, Idiopathic Sudden SensorineuralUnited States, Korea, Republic of, Canada
Clinical Trials on Default CI fitting
-
MED-EL Elektromedizinische Geräte GesmbHCompletedSensorineural Hearing Loss, BilateralFrance
-
MED-EL Elektromedizinische Geräte GesmbHCompletedSensorineural Hearing Loss, BilateralFrance
-
Arizona State UniversityCompleted
-
Advanced BionicsCompletedEar Diseases | Hearing Loss | Hearing Disorders | Otolaryngological DiseaseUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...MED-EL Elektromedizinische Geräte GesmbHRecruiting
-
Yu-Hsiang WuVanderbilt University Medical Center; National Institute on Deafness and Other...CompletedMild Cognitive Impairment | Alzheimer Disease 2 Due to Apoe4 Isoform | Presbycusis, BilateralUnited States
-
Corporal Michael J. Crescenz VA Medical CenterCompletedIdiopathic Pulmonary Fibrosis | COPD | Congestive Heart Failure | Malignancy | Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy | Other Interstitial Lung Disease Without Curative Therapy | NYHA Class IV or NYHA Class III Plus 1 Hospitalization... and other conditionsUnited States
-
Johns Hopkins Bloomberg School of Public HealthEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Bernafon AGTerminatedHearing LossSwitzerland
-
University of WarwickCompletedChronic Disease | Hospital Outpatient ClinicsUnited Kingdom